Literature DB >> 2923558

Ultraviolet light exposure and risk of posterior subcapsular cataracts.

T W Bochow1, S K West, A Azar, B Munoz, A Sommer, H R Taylor.   

Abstract

Posterior subcapsular (PSC) cataracts are a visually disabling form of cataract and account for 40% of surgical cases. Although PSC opacities may occur following intraocular inflammation, trauma, or use of steroids, the cause is often unknown. A case-control study was undertaken to investigate the role of exposure to ultraviolet light in the B range (UV-B) and other potential risk factors for the development of PSC cataracts. Surgical PSC cataract cases from a large rural ophthalmic practice on the lower eastern shore of Maryland were matched with phakic controls without PSC cataract changes from the same geographic area by age, sex, and referral pattern. All patients with PSC opacities who underwent cataract surgery in a 12-month period were chosen. One hundred sixty-eight cases and 168 controls were interviewed regarding sunlight exposure, drug use, occupational history, history of diabetes, hypertension, and other diseases. Matched-pairs analyses indicated that a history of relatively high exposure to UV-B was associated with increased risk of PSC cataracts. The association of PSC cataracts with steroid use and diabetes was reconfirmed. Subjects with blue eyes and less than high school education were also at increased risk for PSC cataracts. Smoking and hypertension were not found to be PSC cataract risk factors. These data suggest that UV-B exposure may be an important risk factor for PSC cataracts.

Entities:  

Mesh:

Year:  1989        PMID: 2923558     DOI: 10.1001/archopht.1989.01070010379027

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  29 in total

Review 1.  Prevention strategies for age related cataract: present limitations and future possibilities.

Authors:  N G Congdon
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

2.  The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.

Authors:  Tanya S Glaser; Lauren E Doss; Grace Shih; Divya Nigam; Robert D Sperduto; Frederick L Ferris; Elvira Agrón; Traci E Clemons; Emily Y Chew
Journal:  Ophthalmology       Date:  2015-05-09       Impact factor: 12.079

3.  Antioxidants: Basis concepts in relation to the eye.

Authors:  P Venkatesh; G Satpal; L Verma; T H Kumar; S Garg
Journal:  Indian J Clin Biochem       Date:  2001-01

4.  Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5.

Authors: 
Journal:  Ophthalmology       Date:  2001-08       Impact factor: 12.079

5.  Retrobulbar blood flow in patients with cataract.

Authors:  M C Grieshaber; I Koçak; B Dubler; J Flammer; S Orgül
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

6.  The objective clinical assessment of the quality of the anterior segment by means of the Oqual.

Authors:  R F Lobo; R A Weale
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 7.  Ultraviolet radiation and cataract: a review of the epidemiological evidence.

Authors:  P J Dolin
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

8.  Progression of myopia.

Authors:  R H Kennedy
Journal:  Trans Am Ophthalmol Soc       Date:  1995

9.  Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.

Authors:  Jessica R Chang; Euna Koo; Elvira Agrón; Joelle Hallak; Traci Clemons; Dimitri Azar; Robert D Sperduto; Frederick L Ferris; Emily Y Chew
Journal:  Ophthalmology       Date:  2011-11       Impact factor: 12.079

10.  Sunlight exposure, antioxidant status, and cataract in Hong Kong fishermen.

Authors:  L Wong; S C Ho; D Coggon; A M Cruddas; C H Hwang; C P Ho; A M Robertshaw; D M MacDonald
Journal:  J Epidemiol Community Health       Date:  1993-02       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.